Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma

Table 3

Multivariate analysis of clinicopathologic features on OS from time of metastasis.

	HR	95% lower	95% upper	value
Age (>56 versus ≤56)	1.36	1.01	1.84	0.045
Gender (M versus F)	1.42	1.05	1.92	0.023
Number of metastatic sites (≥3 versus <3)	1.49	1.10	2.03	0.011
Time to metastatic disease (cont.)	0.92	0.84	1.01	0.078